Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells
Citations Over TimeTop 10% of 2015 papers
Abstract
Multidrug resistance (MDR) in cancer cells is a challenging phenomenon often associated with P-glycoprotein (Pgp) surface expression. Finding new ways to bypass Pgp-mediated MDR still remains a daunting challenge towards the successful treatment of malignant neoplasms such as colorectal cancer.We applied the Cell Surface Capture technology to chemosensitive and chemoresistant human colon cancer to explore the cell surface proteome of Pgp-expressing cells in a discovery-driven fashion. Comparative quantitative analysis of identified cell surface glycoproteins revealed carbonic anhydrase type XII (CAXII) to be up-regulated on the surface of chemoresistant cells, similarly to Pgp. In cellular models showing an acquired MDR phenotype due to the selective pressure of chemotherapy, the progressive increase of the transcription factor hypoxia-inducible factor-1 alpha was paralleled by the simultaneous up-regulation of Pgp and CAXII. CAXII and Pgp physically interacted at the cell surface. CAXII silencing or pharmacological inhibition with acetazolamide decreased the ATPase activity of Pgp by altering the optimal pH at which Pgp operated and promoted chemosensitization to Pgp substrates in MDR cells.We propose CAXII as a new secondary marker of the MDR phenotype that influences Pgp activity directly and can be used as a pharmacological target for MDR research and potential treatment.
Related Papers
- → Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer(2003)161 cited
- → Thirty-Day Morbidity after Simultaneous Resection of Colorectal Cancer and Colorectal Liver Metastasis: American College of Surgeons NSQIP Analysis(2020)60 cited
- Recurrent pattern of digestive tract carcinoma in the Japanese: comparison of gastric cancer to colon cancer.(1995)
- Analysis of the Risk Factors of Postoperative Recurrence for Elderly Patients with Colorectal Cancer(2013)
- → In-vivo anti colorectal cancer activity of Coldenia procumbens on DMH induced colon cancer in wistar rats(2020)